316 related articles for article (PubMed ID: 15747374)
1. Cryosurgical ablation of the prostate: high risk patient outcomes.
Prepelica KL; Okeke Z; Murphy A; Katz AE
Cancer; 2005 Apr; 103(8):1625-30. PubMed ID: 15747374
[TBL] [Abstract][Full Text] [Related]
2. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry.
Jones JS; Rewcastle JC; Donnelly BJ; Lugnani FM; Pisters LL; Katz AE
J Urol; 2008 Aug; 180(2):554-8. PubMed ID: 18550117
[TBL] [Abstract][Full Text] [Related]
3. Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up.
Ragde H; Korb LJ; Elgamal AA; Grado GL; Nadir BS
Cancer; 2000 Jul; 89(1):135-41. PubMed ID: 10897010
[TBL] [Abstract][Full Text] [Related]
4. Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology.
Polascik TJ; Nosnik I; Mayes JM; Mouraviev V
Urology; 2007 Jul; 70(1):117-21. PubMed ID: 17656220
[TBL] [Abstract][Full Text] [Related]
5. Salvage prostate cryoablation: initial results from the cryo on-line data registry.
Pisters LL; Rewcastle JC; Donnelly BJ; Lugnani FM; Katz AE; Jones JS
J Urol; 2008 Aug; 180(2):559-63; discussion 563-4. PubMed ID: 18554664
[TBL] [Abstract][Full Text] [Related]
6. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results.
Demanes DJ; Rodriguez RR; Schour L; Brandt D; Altieri G
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1306-16. PubMed ID: 15817332
[TBL] [Abstract][Full Text] [Related]
7. Natural history of disease progression in patients who fail to achieve an undetectable prostate-specific antigen level after undergoing radical prostatectomy.
Rogers CG; Khan MA; Craig Miller M; Veltri RW; Partin AW
Cancer; 2004 Dec; 101(11):2549-56. PubMed ID: 15470681
[TBL] [Abstract][Full Text] [Related]
8. Monotherapeutic brachytherapy for clinically organ-confined prostate cancer.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Adamovich E
W V Med J; 2005; 101(4):168-71. PubMed ID: 16296198
[TBL] [Abstract][Full Text] [Related]
9. Short-term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy.
Bales GT; Williams MJ; Sinner M; Thisted RA; Chodak GW
Urology; 1995 Nov; 46(5):676-80. PubMed ID: 7495120
[TBL] [Abstract][Full Text] [Related]
10. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
[TBL] [Abstract][Full Text] [Related]
11. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer.
Lambert EH; Bolte K; Masson P; Katz AE
Urology; 2007 Jun; 69(6):1117-20. PubMed ID: 17572198
[TBL] [Abstract][Full Text] [Related]
12. Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
Momma T; Saito S; Toya K; Yorozu A; Dokiya T; Murai M
Int J Urol; 2006 Mar; 13(3):218-23. PubMed ID: 16643612
[TBL] [Abstract][Full Text] [Related]
13. Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up.
Chaplin BJ; Wildhagen MF; Schroder FH; Kirkels WJ; Bangma CH
Eur Urol; 2005 Dec; 48(6):906-10. PubMed ID: 16126322
[TBL] [Abstract][Full Text] [Related]
14. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
Kupelian P; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A; Kuban D
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):795-9. PubMed ID: 15925452
[TBL] [Abstract][Full Text] [Related]
15. Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO criterion--"nadir + 2"?
Nielsen ME; Makarov DV; Humphreys E; Mangold L; Partin AW; Walsh PC
Urology; 2008 Aug; 72(2):389-93; discussion 394-5. PubMed ID: 18279937
[TBL] [Abstract][Full Text] [Related]
16. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML
J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
[TBL] [Abstract][Full Text] [Related]
17. Cryoablation as primary treatment for localized prostate cancer followed by penile rehabilitation.
Ellis DS; Manny TB; Rewcastle JC
Urology; 2007 Feb; 69(2):306-10. PubMed ID: 17320669
[TBL] [Abstract][Full Text] [Related]
18. Radical prostatectomy for high-risk prostate cancer: biochemical outcome.
Kawamorita N; Saito S; Ishidoya S; Ito A; Saito H; Kato M; Arai Y
Int J Urol; 2009 Sep; 16(9):733-8. PubMed ID: 19674167
[TBL] [Abstract][Full Text] [Related]
19. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.
Sengupta S; Blute ML; Bagniewski SM; Inman B; Leibovich BC; Slezak JM; Myers RP; Zincke H
BJU Int; 2008 Jan; 101(2):170-4. PubMed ID: 18173824
[TBL] [Abstract][Full Text] [Related]
20. "Male lumpectomy": focal therapy for prostate cancer using cryoablation.
Onik G; Vaughan D; Lotenfoe R; Dineen M; Brady J
Urology; 2007 Dec; 70(6 Suppl):16-21. PubMed ID: 18194706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
